Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback